Z. Mariño

X. Forns, Z. Mariño, S. Lens, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A. Forner, X. Forns, M. Londoño, 2020, Journal of hepatology.

New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C

T. Berg, X. Forns, Z. Mariño, 2013, Gut.

Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.

J. Bruix, A. Forner, X. Forns, 2021, Journal of hepatology.

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.

X. Forns, J. Sánchez-Tapias, M. Bonacci, 2018, Gastroenterology.

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus–Associated Cryoglobulinemia Treated With Direct‐Acting Antivirals

X. Forns, J. Sánchez-Tapias, M. Bonacci, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reply to: "Response to Mariño et al. J Hep 2019 Study: The reported 'clear cut time association between interferon-free treatment and HCC' is anything but clear cut".

J. Bruix, X. Forns, Z. Mariño, 2019, Journal of hepatology.

Considerations for optimizing Wilson’s disease patients’ long-term follow-up

X. Forns, Y. Compta, Z. Mariño, 2022, Gastroenterología y Hepatología (English Edition).

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

J. Bruix, X. Forns, B. Sangro, 2019, Journal of hepatology.

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

X. Forns, H. Dahari, F. Graw, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease

Z. Mariño, M. Berenguer, P. Jara, 2016 .

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients

F. Zoulim, X. Forns, E. García-Pras, 2020, Journal of hepatology.

Beyond the achievement of sustained virological response after liver transplantation

X. Forns, Z. Mariño, S. Lens, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy.

X. Forns, M. Bonacci, M. Londoño, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus‐specific CD8+ T cells after direct‐acting antiviral therapies

X. Forns, M. Londoño, G. Koutsoudakis, 2020, Journal of viral hepatitis.

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals

X. Forns, R. Navinés, R. Martin-Santos, 2019, Revista brasileira de psiquiatria.

Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C

X. Forns, M. Navasa, J. Bosch, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hepatitis C virus early kinetics and resistance‐associated substitution dynamics during antiviral therapy with direct‐acting antivirals

X. Forns, F. González-Candelas, C. Perales, 2018, Journal of viral hepatitis.

Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals.

M. Buti, X. Forns, J. Esteban, 2020, Journal of hepatology.

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis.

X. Forns, J. Calleja, J. Crespo, 2015, Journal of hepatology.

Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients.

J. Dufour, X. Forns, W. Rosenberg, 2018, Journal of hepatology.

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy

X. Forns, M. Maini, M. Londoño, 2020, Frontiers in Immunology.

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

X. Forns, Z. Mariño, S. Lens, 2022, JHEP reports : innovation in hepatology.

ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study.

Rosa Gilabert, Gonzalo Crespo, Xavier Forns, 2012, Journal of hepatology.

Efficacy of an accelerated double‐dose hepatitis B vaccine regimen in patients with cirrhosis

X. Forns, Z. Mariño, S. Lens, 2021, Journal of viral hepatitis.

Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

X. Forns, M. Laguno, Z. Mariño, 2020, Journal of viral hepatitis.

Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone

X. Forns, J. Sánchez-Tapias, M. Bonacci, 2018, Alimentary pharmacology & therapeutics.

HEV infection in two referral centers in Spain: epidemiology and clinical outcomes.

X. Forns, M. Navasa, M. Londoño, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak

X. Forns, G. Koutsoudakis, Z. Mariño, 2019, Journal of medical virology.

Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January‐June 2017: A hospital perspective

X. Forns, G. Koutsoudakis, Z. Mariño, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C.

X. Forns, J. Sánchez-Tapias, J. Calleja, 2015, World journal of gastroenterology.

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

J. Bruix, J. Dufour, X. Forns, 2021, Gut.

Effectiveness and Safety of Sofosbuvir/Velpatasvir/ Voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs.

M. Buti, S. Llerena, B. Figueruela, 2019, Journal of hepatology.

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

M. Buti, X. Forns, Z. Mariño, 2020, Journal of gastroenterology and hepatology.

“Targeting” hepatitis C after liver transplantation

X. Forns, M. Londoño, Z. Mariño, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

X. Forns, M. Navasa, J. García‐Pagán, 2018, Hepatology.

Efficacy and safety of direct-acting antivirals in older patients with cirrhosis and high comorbidity index

X. Forns, Z. Mariño, S. Lens, 2020, European journal of gastroenterology & hepatology.

[Inflammatory bowel disease: should all patients be premedicated when infliximab is administered to reduce infusion reactions and/or immunogenicity?].

Z. Mariño, D. Ginard, 2008, Gastroenterologia y hepatologia.

Hepatitis C treatment for patients post liver transplant

X. Forns, M. Londoño, Z. Mariño, 2015, Current opinion in organ transplantation.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

X. Forns, M. Durlik, J. Calleja, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Low risk of viral hepatitis amongst patients with severe mental disorders.

X. Forns, J. Goikolea, Z. Mariño, 2023, Liver international : official journal of the International Association for the Study of the Liver.

A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients

X. Forns, M. Navasa, I. Martínez‐Arranz, 2017, Scientific Reports.

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation

X. Forns, M. Navasa, J. Bosch, 2013, Journal of Gastroenterology.

Elastography is unable to exclude cirrhosis after sustained virological response in HCV‐infected patients with advanced chronic liver disease

X. Forns, M. Vergara, Z. Mariño, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct‐acting anti‐virals

X. Forns, C. Badenas, P. Aguilera, 2020, Alimentary pharmacology & therapeutics.

Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6)

X. Forns, T. Pilot‐Matias, D. Samuel, 2017 .

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon

M. Juan, X. Forns, J. Sánchez-Tapias, 2016, PloS one.

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C

X. Forns, M. Londoño, S. M. Martínez, 2016, Alimentary pharmacology & therapeutics.

Tumour recurrence after Interferon-free treatment for hepatitis C in patients with previously treated hepatocellular carcinoma discloses a more aggressive pattern and faster tumour growth

J. Bruix, X. Forns, B. Sangro, 2017 .

Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response

X. Forns, G. Casanovas, J. García‐Pagán, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Improvement of sexuality after hepatitis C cure with direct acting antivirals

X. Forns, R. Navinés, M. Londoño, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation.

X. Forns, M. Navasa, R. Miquel, 2014, Journal of hepatology.

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

X. Forns, M. Durlik, J. Calleja, 2015 .

Simple prediction of long‐term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation

X. Forns, M. Navasa, M. Londoño, 2016, Transplant International.

Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy

X. Forns, M. Navasa, S. M. Martínez, 2011, European journal of gastroenterology & hepatology.

Chronic inflammation in hepatitis C patients is associated with increased perceived stress and abnormal connectivity between insula and basal ganglia

J. Leza, X. Forns, R. Navinés, 2018, European Neuropsychopharmacology.

Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".

J. Bruix, X. Forns, Z. Mariño, 2019, Journal of hepatology.

Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing".

J. Bruix, X. Forns, Z. Mariño, 2016, Journal of hepatology.

Severity of Liver Disease Affects HCV Kinetics in Patients Treated with Intravenous Silibinin Monotherapy

A. Perelson, X. Forns, H. Dahari, 2014, Antiviral therapy.

Recent advances in diagnosis and management of Wilson disease.

Z. Mariño, 2023, Revista espanola de enfermedades digestivas.